Correlation Between Nanhua Bio and Qingdao Haier

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nanhua Bio and Qingdao Haier at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nanhua Bio and Qingdao Haier into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nanhua Bio Medicine and Qingdao Haier Biomedical, you can compare the effects of market volatilities on Nanhua Bio and Qingdao Haier and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nanhua Bio with a short position of Qingdao Haier. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nanhua Bio and Qingdao Haier.

Diversification Opportunities for Nanhua Bio and Qingdao Haier

0.81
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Nanhua and Qingdao is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Nanhua Bio Medicine and Qingdao Haier Biomedical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Qingdao Haier Biomedical and Nanhua Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nanhua Bio Medicine are associated (or correlated) with Qingdao Haier. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Qingdao Haier Biomedical has no effect on the direction of Nanhua Bio i.e., Nanhua Bio and Qingdao Haier go up and down completely randomly.

Pair Corralation between Nanhua Bio and Qingdao Haier

Assuming the 90 days trading horizon Nanhua Bio Medicine is expected to under-perform the Qingdao Haier. But the stock apears to be less risky and, when comparing its historical volatility, Nanhua Bio Medicine is 1.01 times less risky than Qingdao Haier. The stock trades about -0.01 of its potential returns per unit of risk. The Qingdao Haier Biomedical is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  3,142  in Qingdao Haier Biomedical on September 4, 2024 and sell it today you would earn a total of  232.00  from holding Qingdao Haier Biomedical or generate 7.38% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Nanhua Bio Medicine  vs.  Qingdao Haier Biomedical

 Performance 
       Timeline  
Nanhua Bio Medicine 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Nanhua Bio Medicine are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Nanhua Bio sustained solid returns over the last few months and may actually be approaching a breakup point.
Qingdao Haier Biomedical 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Qingdao Haier Biomedical are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Qingdao Haier sustained solid returns over the last few months and may actually be approaching a breakup point.

Nanhua Bio and Qingdao Haier Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nanhua Bio and Qingdao Haier

The main advantage of trading using opposite Nanhua Bio and Qingdao Haier positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nanhua Bio position performs unexpectedly, Qingdao Haier can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Qingdao Haier will offset losses from the drop in Qingdao Haier's long position.
The idea behind Nanhua Bio Medicine and Qingdao Haier Biomedical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio